[Systemic treatment of common warts with beta-interferon].
A 21-year-old female suffering from recalcitrant subungual and periungual common warts was treated without success for 3 years by both conservative and surgical approaches. After intravenous therapy with human fibroblast beta interferon (IFN-beta; 3 cycles, 14 days each; daily dose 1-3 x 10(6) IU) complete remission of all warts was achieved. Even 1 year after the treatment with human IFN-beta, the patient was still free of warts. We conclude that in selected cases common warts can be treated with intravenous human fibroblast IFN-beta. However, because of the high cost of this well-tolerated therapy, it cannot be recommended for all patients with common warts.
Schöfer
H
H
Zentrum der Dermatologie und Venerologie, Abteilung II, Universitätsklinik Frankfurt a.M.
Sollberg
S
S
D000328:Adult; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D016899:Interferon-beta / Q000008:administration & dosage*; D014860:Warts / Q000628:therapy*
D016899:Interferon-beta
Systemische Behandlung vulgärer Warzen mit beta-Interferon.